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A B S T R A C T
Purpose: Emergent EEG (eEEG) is an EEG performed on a non-elective basis upon request from a clinician
for a seemingly emergency indication. Little is known about the long-term prognosis of patients with
emergent periodic lateralized epileptiform discharges (ePLEDs).
Methods: We analyzed the EEG and clinical records of patients with ePLEDs from January 2002 to
December 2008.
Results: Out of 1948 eEEGs, 79 (4%) patients had ePLEDs. Sixty-three patients had ePLEDs and 16 had
eBiPLEDs (emergent bilateral periodic lateralized epileptiform discharges). The etiology of ePLEDs was
CNS infection and inﬂammation (35.4%), stroke (32.9%), and metabolic encephalopathy (11.4%). Of the
surviving 52 (65.8%) patients with ePLEDs, 34 (65.4%) had persistent seizures during a mean follow-up of
28 months (range 12–72 months). Seizure as the initial presentation was more commonly seen in
children as compared to adults (64% versus 31%, p = 0.005). CNS infection and inﬂammation were also
seen more frequently in the pediatric age group (50% versus 27%, p = 0.04). At follow-up, patients with
eBiPLEDs had more seizures than patients with ePLEDs (87.5% versus 61.3%).
Conclusion: ePLEDs is associated with signiﬁcant morbidity and mortality. However, the etiology of
ePLEDs and brain dysfunction will inﬂuence the long-term outcome. This information is invaluable for
prognostication and underscores the importance of rigorous management of patients with ePLEDs.
 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at SciVerse ScienceDirect
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Periodic lateralized epileptiform discharges (PLEDs) in electro-
encephalography (EEG) and their etiopathogenesis, relation to
seizures, prognostic implications including morbidity and mortality
have been discussed by many authors.1–6 They can occur in acute
and chronic cerebrovascular disorders (infarcts and hemorrhages),
brain infections and inﬂammation (Herpes simplex encephalitis, La
Crosse virus encephalitis, subacute sclerosing panencephalitis,
Creutzfeldt–Jacob disease, neuro-dengue, neuro-tuberculosis, syph-
ilis and neurocysticercosis), cerebral tumors, trauma, and metabolic
dysfunction.7–12 PLEDs and bilateral independent periodic later-
alized epileptiform discharges (BiPLEDs) have been considered by
many as an ‘‘indication for impending seizures’’ which need
aggressive management with anti-epileptic medications (AEDs).13
We have previously described emergent EEG (eEEG) as ‘‘any
EEG done on an emergency basis’’. 10 PLEDs occur in both emergent
and non-emergent settings and forms 0.1–1% of the total EEGs in* Corresponding author at: Department of Neurology, Sree Chitra Tirunal
Institute for Medical Sciences and Technology, Trivandrum, Kerala 695011, India.
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http://dx.doi.org/10.1016/j.seizure.2012.04.011any established electrophysiology laboratory.6,10,12 The available
data on the incidence and prevalence of PLEDs among the eEEGs
(ePLEDs) is sparse and variable.10,14 In patients diagnosed with
epilepsy, whose serial EEGs show PLEDs, the management is not
inﬂuenced by their presence. However, in an acute setting, the
presence of PLEDs in eEEG has diagnostic and prognostic
implications. Very few studies have looked into the long-term
prognosis and seizure control in patients with ePLEDs which is of
utmost importance to a treating clinician.
Hence, we undertook the present study in patients having
ePLEDs in their eEEG with the following objectives:
1) To critically analyze the clinical and demographic proﬁle,
etiology as well as the electrophysiological and imaging
characteristics of patients with ePLEDs.
2) To elucidate the outcome with regards to seizure control and
functional disability if any, in the long-term.
2. Materials and methods
2.1. Study site and subjects
This retrospective study was carried out in the Electroenceph-
alography and Clinical Neurophysiology Service (EEG-CNP) of thevier Ltd. All rights reserved.
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Medical Sciences and Technology, situated at Trivandrum, India.
This center offers advanced care for all neurological emergencies,
especially for all epilepsy syndromes. The EEG-CNP section carries
out around 10–15 digital EEGs every day in addition to maintaining
six prolonged video EEG suites for presurgical evaluation of drug-
resistant epilepsy. We offer eEEG service in the neurophysiology
laboratory or at patient’s bedside and in the critical care suites
round the clock. The EEG registers and computerized EEG reports
were thoroughly scrutinized with search words – eEEG, PLEDs,
BiPLEDs, generalized periodic epileptiform discharges (GPEDs),
and other periodic discharges (spikes and/or sharp waves) from
January 2002 to December 2008. The total number of eEEGs done
during the study period was analyzed and the eEEGs showing
PLEDs and BiPLEDs were separately identiﬁed and scrutinized. The
case records and clinical ﬁndings were analyzed in detail from the
systematically maintained database of our Institute. The informa-
tion on clinical proﬁle, investigations, treatment given and follow-
up characteristics were abstracted in a structured proforma.
Clustering of seizures was deﬁned as the occurrence of three or
more seizures over 24 h witnessed and/or recorded by continuous
EEG (cEEG) monitoring. The patients who were lost to follow-up
for clinical review were traced by telephonic interview and/or
postal review.
2.2. Recording of EEG
All recordings were carried out on a 16-channel digital EEG
acquisition system (NicVue, Nicolet-Viking, USA) with the scalp
electrodes placed according to the International 10–20 system.
Standard activation procedures were employed whenever possi-
ble. Response to pain and other physiological stimuli were
recorded in patients with altered sensorium. All eEEGs were
obtained for a minimum of 30 min. Whenever possible, both
awake and sleep record was obtained and if required, irritable and
unmanageable patients were sedated with non-benzodiazepine
sedatives. All the EEGs with ePLEDs were analyzed by a senior
epileptologist (AR) involved in the study.
2.3. Classiﬁcation and deﬁnition of ePLEDs
1. ePLEDs – lateralized or focal, periodic or near-periodic spike,
spike wave or sharp-wave complex persisting for 75% or whole
of the recording.
2. eBiPLEDs – bihemispheric, asynchronous, periodic or near-
periodic spike, spike wave or sharp-wave complex in two
hemispheres persisting for 75% or whole of the recording.
When multiple records were available, the ﬁrst record with
deﬁned PLEDs or BiPLEDs was considered as ‘‘the index EEG’’.
2.4. Neuroimaging scans
Computerized tomography scan (CT, single slice (10 mm), GE,
USA) and Magnetic Resonance Imaging (MRI, 1.5 T, Magnetom
Avanto TIM, Seimens, USA) were reviewed in detail by scrutinizing
the ﬁlms of each patient. All patients had at least a single MRI done
during the hospital stay. MRI was done according to an emergency
protocol including T1 weighted images, T2 weighted images, and
ﬂuid attenuated inversion recovery sequences (FLAIR). Diffusion
weighted imaging (DWI), apparent diffusion coefﬁcient (ADC) and
post-gadolinium contrast imaging were done if required. Although
CT scan was available in majority of the patients, MRI was
preferred for the evaluation of the degree and extent of
involvement of brain parenchyma. The MRI ﬁndings were
classiﬁed into ﬁve sub categories by the Neuroradiologist. Grade 1: MRI did not reveal any abnormality in any of the scans
taken during the acute phase of illness.
 Grade 2: Predominant gray-matter involvement, affecting less
than or equal to two contiguous lobes of the same hemisphere.
 Grade 3: Predominant white-matter involvement, affecting less
than or equal to two contiguous lobes of the same hemisphere.
 Grade 4: Both gray and white-matter involvement, affecting less
than or equal to two contiguous lobes of the same hemisphere.
 Grade 5: Grey-matter or white-matter or both involved in more
than two lobes of one or both hemispheres.
2.5. Outcome measures
The outcome parameters analyzed were: Glasgow coma scale
(GCS), presence or absence of seizures at entry, discharge and
follow-up, morbidity and mortality. Favorable outcome was
deﬁned as seizure freedom with or without antiepileptic drugs
during follow-up. Unfavorable outcome was deﬁned as the
presence of any type of seizures during follow-up. All deaths
occurring while in the hospital or after discharge from the hospital
were noted. Various electro-clinical features, neuroimaging
characteristics and etiological factors which adversely affected
the outcome were analyzed. The long-term functional disability
was assessed by Modiﬁed Rankin Scale (MRS). The scale runs from
0 to 6, running from perfect health without symptoms to death.
0 – No symptoms.
1 – No signiﬁcant disability: Able to carry out all usual activities,
despite some symptoms.
2 – Slight disability: Able to look after own affairs without
assistance, but unable to carry out all previous activities.
3 – Moderate disability: Requires some help, but able to walk
unassisted.
4 – Moderately severe disability: Unable to attend to own bodily needs
without assistance, and unable to walk unassisted.




The demographic data and variables were expressed using
descriptive statistics as percentages, mean  standard deviation,
median and range. The Fisher’s exact test, Chi-square test and
Student’s t test was used as appropriate. A p value 0.05 was taken as
signiﬁcant. All the statistical analysis were done by SPSS version 15.0
(SPSS Inc., Chicago, IL, U.S.A.).
3. Results
3.1. Electro-clinical characteristics of patients with ePLEDs
During the study-period, 17,346 EEGs were carried out, of
which 1948 (11.2%) were eEEGs. After the preliminary search, 191
patient records with PLEDs were identiﬁed. One hundred and
twelve records (58.6%) were excluded due to various reasons (53 in
whom the initial report carried the diagnosis of PLEDs, but later
review of the EEG and/or reports did not satisfy the criteria for
PLEDs; 41 were duplicate records and in 18, neither the EEGs nor
their reports were retrievable for later review). Out of 1948 eEEGs,
ePLEDs were identiﬁed in 79 (4%) patients and were ﬁnally
included in the study (see Fig. 1). Of the 79 patients, 63 (79.7%) had
ePLEDs and 16 (20.3%) had eBiPLEDs respectively. Forty-ﬁve
patients were males and 28 patients were children (below 18 years
Fig. 1. Flow chart showing the number of patients with ePLEDs.
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eBiPLEDs together was 26 years (range 4 months to 82 years)
(Table 1). The median GCS at admission was 11 (range 3–15) in
patients with ePLEDs and 6 (range 3–15) in patients with eBiPLEDs.
The most common symptom at presentation in patients with both
ePLEDs and eBiPLEDs was altered sensorium (59, 74.7%) followed
by seizures (34, 43%). Eight (10.1%) patients had no seizures at
entry when their index EEG showed ePLEDs or eBiPLEDs. Twenty-
seven (34.1%) patients died during their ﬁrst hospitalization and
the mean duration of hospital stay was 25 days (range 1–160 days).
Altered sensorium at onset was observed signiﬁcantly more in
patients with eBiPLEDs than in those with ePLEDs (Table 1,
p = 0.008). Seizures at presentation were more common in ePLEDs
than eBiPLEDs (p = 0.04).
3.2. EEG features and seizure patterns in ePLEDs
The EEG features and seizure patterns in patients with ePLEDs
are described in Table 2. ePLEDs were most commonly seen in
fronto-central and fronto-temporal regions (45, 63.38%) followed
by centro-temporal and temporo-parieto-occipital regions (20,
28.16%) in patients with seizures. Poor background activity
comprising of medium-high amplitude, polymorphic, theta–delta
frequency (3–7 Hz) was noted in all the patients with seizures. TheTable 1
Clinical, etiologic and neuroimaging characteristics of patients with ePLEDs (n = 79).
Groups ePLEDs (n = 63, 79.7%) 
Median age (years) 28 
Sex (male:female) 37:26 
Median GCS on admission 11 
Altered consciousness at presentation 43 (68.3%) 
Seizures at onset of illness 31 (49.2%) 
Seizures at entry into hospital 7 (11.1%) 
Stroke 23 (36.5%) 
CNS infection/inﬂammation 19 (30.2%) 
Metabolic encephalopathy 7 (11.1%) 
Others 14 (22.2%) 
Mortality 19 (30.2%) 
Neuroimagea: Grade 1 15 (23.8%) 
Grade 2 12 (19.0%) 
Grade 3 10 (15.87%) 
Grade 4 14 (22.2%) 
Grade 5 12 (19.0%) 
a See text for deﬁnition. ePLEDs – emergent periodic lateralized epileptiform discharge
Glasgow Coma Scale.
* p by Chi-square test/Fisher exact test/t test. NS – not signiﬁcant, n – number.complexes were spike, spike-wave, or sharp-wave complexes.
PLEDs at discharge from the hospital were seen in 12 (23%) patients
after a mean hospital stay of 25 days (1–160 days). Though the data
did not achieve statistical signiﬁcance, 20% of patients with
eBiPLEDs and 16% of ePLEDs in their index EEG had persistence of
PLEDs at the time of discharge from the hospital (Table 2).
Secondary generalized seizures occurred in 60 (84.5%) patients.
Clustering of seizures were noted in 58 (73.4%) patients and 7
(9.8%) patients had epilepsia partialis continua (EPC). Status
epilepticus (SE) at presentation was seen in 29 (40.8%) during the
acute phase of illness, eight of whom expired during hospitaliza-
tion. The mean duration of hospitalization was 25 days (1–160
days). Three patients presented with myoclonic status, two had
complex partial status and rest had generalized status epilepticus.
We treated patients with seizures, status epilepticus and acute
neurological disorders as per the standard institutional protocol. In
nine (26.4%) patients who presented with seizures and ePLEDs/
eBiPLEDs in their EEG, benzodiazepines (Lorazepam) were given to
abort the seizures. Other patients (73.6%) needed further aggres-
sive treatment for control of seizures during the hospital stay.
Examples of ePLEDs and eBiPLEDs are shown in Fig. 2.
3.3. Etiological association
The most common causal association was central nervous
system infection and inﬂammation (35.4%), followed by stroke
(32.9%) and metabolic encephalopathy in 9 patients (11.4%,
hyponatremia-3, hypoglycemia-3, hepatic encephalopathy-1, sys-
temic infection with sepsis-2). CNS infection and inﬂammation
were more common with eBiPLEDS than ePLEDs (p = 0.05). Among
the CNS infections, herpes simplex encephalitis was proven in 7
(25%), and encephalitis of obscure etiology in another 13 (42.8%)
patients. PLEDs in sub-acute sclerosing pan encephalitis, Creutz-
feldt–Jacob disease, neuro-lupus and acute disseminated enceph-
alomyelitis were observed in one each. Four patients with
Rasmussen’s encephalitis presented as seizures and EEG showed
ePLEDs.
3.4. Comparison of children versus adults
The comparison of pediatric versus adult patients is shown in
Table 3. Seizure as the initial presentation was more commonly
seen in children as compared to adults (64% versus 31%, p = 0.005).
CNS infection and inﬂammation was frequently seen in pediatric




16 (100.0%) 59 (74.7%) 0.008
3 (18.7%) 34 (43.0%) 0.04
1 (6.2%) 8 (10.1%) NS
3 (18.7%) 26 (32.9%) NS
9 (56.2%) 28 (35.4%) 0.05
2 (12.5%) 9 (11.4%) NS
2 (12.5%) 16 (20.2%) NS
8 (50.0%) 27 (34.2%) NS
3 (18.7%) 18 (22.8%) NS
2 (12.5%) 14 (17.7%) NS
2 (12.5%) 12 (15.1%) NS
3 (18.7%) 17 (21.5%) NS
6 (37.5%) 18 (22.7%) NS
s; eBiPLEDs – emergent bilateral periodic lateralized epileptiform discharges; GCS –
Table 2
Seizure types and EEG characteristics in patients with ePLEDs (n = 71a).
ePLEDs (n = 56) eBiPLEDs (n = 15) Total (n = 71) p* value
CPS/SPS 10 (17.8%) 1 (6.6%) 11 (15.5%) NS
Generalized seizure (s) 46 (82.1%) 14 (93.3%) 60 (84.5%) NS
Status epilepticus 20 (35.7%) 9 (60%) 29 (40.8%) NS
EPC 6 (10.7%) 1 (6.6%) 7 (9.8%) NS
Periodicity (s) 1.01 0.75 0.88 NS
PLEDs at discharge in survivors (n = 52) 9 (17.0%) 3 (20.0%) 12 (23%) NS
a n = 71 (71/79 patients with ePLEDs had seizures at any time during their illness).
* p by Chi-square test/Fisher exact test/t test, NS – not signiﬁcant, CPS – complex partial seizures, SPS – simple partial seizure, EPC – epilepsia partialis continua, ePLEDs –
emergent periodic lateralized epileptiform discharges, eBiPLEDs – emergent bilateral independent periodic lateralized epileptiform discharge.
Table 3
Comparison of attributes of pediatric and adult patients with ePLEDs.
Characteristics Children (n = 28, 35.44%) Adults (n = 51, 64.55%) Total (n = 79, 100%) p* value
Age (years) 8 (0.4–18) 52 (19–82) 26 NS
Sex (male:female) 18:10 27:24 45:34 NS
Seizures at onset of illness 18 (64.3%) 16 (31.4%) 34 (43%) 0.005
Stroke 6 (21.4%) 20 (39.2%) 26 (32.9%) NS
CNS infection/inﬂammation 14 (50%) 14 (27.4%) 28 (32.9%) 0.04
Persistent seizures at follow-up in survivors 15 (71.4%) 19 (61.3%) 34 (65.4%) NS
Median MRS at follow-up 2 3 2 NS
Died 7 (25%) 20 (39.2%) 27 (34.2%) NS
* p by Chi-square test/Fisher exact test/t test, NS – not signiﬁcant, ePLEDs – emergent periodic lateralized epileptiform discharges, MRS – modiﬁed Rankin Scale.
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The imaging was normal (Grade 1) in 18 (22.8%) patients. Grade
2 lesions were present in 14 (17.7%) and Grade 3 lesions were
noted in 12 (15.1%) patients. A comparison of the distribution of
lesions in ePLEDs and eBiPLEDs group showed no signiﬁcant
difference (Table 1 and Fig. 3).
3.6. Outcome of patients with ePLEDs
The outcome of patients with ePLEDs is summarized in Table 4.
The mean duration of follow-up was 28 months (range 12–66
months). Thirty-four (65.4%) had persistent seizures (unfavorable
outcome), either simple partial seizures (SPS) in 10 (29.4%) or
complex partial seizures (CPS) in 24 (70.5%) during follow-up. The
patients in eBiPLEDs group had poor seizure outcome as compared
to ePLEDs (87.5% versus 61.4%). Out of 27 in-hospital deaths, 19
patients had eBiPLEDs and 8 had ePLEDs in their index EEG. Of the
13 patients who were lost for regular review and detailed clinical
examination, 6 were reported to be dead and the rest had
persistent seizures ascertained by telephonic/postal review. The
median MRS grade was 2 and 3 for patients with ePLEDs and
eBiPLEDs respectively (Table 4). Univariate analysis showed that
impaired consciousness (p = 0.03), and seizures at presentation
(p = 0.005) adversely affected the long-term seizure outcome.
Patients with CNS infection or inﬂammation had persistent
seizures during follow-up (p = 0.05) (Table 5).
4. Discussion
PLEDs are one of the least characterized electrical patterns in
EEG in terms of their neuropathological basis of occurrence.
However, PLEDs have been considered as a very useful clinical
marker of acute brain injury. Most of the existing studies consider
emergent and non-emergent PLEDs as a single entity in the same
cohort. We tried to address the importance of emergent PLEDs
(ePLEDs) in a well characterized cohort of patients followed up in a
systematic way.
The prevalence of ePLEDs in eEEG in the present study was 4%
which is comparable to the existing data.6,15 The prevalence ofePLEDs and eBiPLEDs were 3.2% and 0.8% respectively. Seizures
occurred in 90% of our patients and it has been reported in 58–
100% in various patient populations.6 The type of seizures
associated with PLEDs were complex partial seizures (CPS), SPS,
EPCs, secondary generalized seizures and SE.5,16,17 The most
common seizure type that we observed in our study was
secondarily generalized seizures, seen in 84.5% of patients. In
nine (26.4%) patients who presented with seizures and ePLEDs/
eBiPLEDs in their EEG, benzodiazepines was given to abort the
seizures. Other patients (73.6%) needed further aggressive
treatment for control of seizures during the hospital stay. This
implies that a vast majority (more than 90%) who have ePLEDs/
BiPLEDs in their index EEG would require very careful monitoring
and aggressive management of seizures. Despite offering adequate
treatment with different combinations of AEDs with serial
monitoring of EEGs, signiﬁcant mortality occurred in both ePLEDs
and eBiPLEDs group respectively (30 and 50%). This underscores
the utility of performing emergent EEGs to identify ePLEDs and also
the role of diligent management of acute seizures along with the
underlying etiology causing ePLEDs. This further signiﬁes that the
severity of the underlying brain disease is the major determinant of
mortality and that treatment with AEDs has little inﬂuence on
outcome in patients with ePLEDs.
CNS infection and inﬂammation was the most common etiology
(35%), followed by stroke (32%) in patients with ePLEDs. The latter
has been noted to be the most common etiology by many. 16,17
Thirty-ﬁve percent of the cohort were children, in contrast to
previous studies which could probably reﬂect a referral bias. Also,
children are more vulnerable to CNS infection in this part of the
world. Fifty percent of our children with ePLEDs had CNS infection
and/or inﬂammation as compared to 27% of adults. More than two-
third of children presented with seizures as compared to less than
one-third of adults. Also, only 25% of children with ePLEDs died
whereas, mortality was as high as 40% in adults despite active
management. Even in children, it is probably the etiology that
determines the ﬁnal outcome rather than the mere presence of
ePLEDs. This suggests the importance of performing serial
emergent EEG in children with acute brain insults which is
seldom undertaken in many intensive care units. A low prevalence
of PLEDs have been described previously in children where only
Fig. 2. (A) 16-channel digital EEG in bipolar montage with ePLEDs comprising sharp waves with an admixture of low amplitude theta and faster frequencies over the left
posterior head region occurring at a periodicity of approximately 1 s with a normal background of 9–10 Hz alpha in the right posterior head region (sensitivity 10 uv/mm). (B)
16-channel digital EEG in bipolar montage with eBiPLEDs comprising sharp waves over both the hemispheres occurring asynchronously with a variable periodicity ranging
from 2 to 3.5 s with an associated background slowing comprising of low amplitude theta and faster frequencies over both posterior head regions (sensitivity 7 uv/mm).
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time during the course of illness.15,18
Neuroimaging was normal in 23% of our patients. No correlation
was observed between the grades of lesion which signiﬁes the
extent of involvement of brain parenchyma and the occurrence of
ePLEDs. This further underscores the hypothesis that no anatomic
site or degree of damage of cerebral parenchyma can be correlated
with the occurrence or evolution of PLEDs. Despite having a severe
degree of involvement (Grade 5) in neuroimaging (signifying bothTable 4
Seizure and functional outcome in patients with ePLEDs (n = 52).
ePLEDs (n = 44) 
Mean duration of follow-up (months) 31 
Seizures at last follow-up 27 (61.3%) 
MRS 2 
Mortality at discharge 19 (30%) 
* p by Student t test/Fisher exact test, NS – not signiﬁcant, ePLEDs – emergent period
periodic lateralized epileptiform discharges, MRS – modiﬁed Rankin Scale.gray and white matter involvement of both hemispheres), the
distribution of patients in ePLEDs and eBiPLEDs were not different
and their outcome with regard to seizures also did not differ.
However, it should be clearly understood that although the extent
of neuroimaging abnormalities did not correlate with long-term
seizure outcome, the underlying etiology may inﬂuence the
prognosis.
Twelve patients had PLEDs persisting at discharge after a mean
hospital stay of 25 days which is in congruence with the earliereBiPLEDs (n = 8) Total (n = 52) p* value
23 28 NS
7 (87.5%) 34 (65.3%) NS
3 2 NS
8 (50%) 27 (34%) NS
ic lateralized epileptiform discharges, eBiPLEDs – emergent bilateral independent
Fig. 3. FLAIR axial MRI Brain images showing various grades of neuroimaging abnormalities in patients with ePLEDs. (A) Grade 1: Normal. (B) Grade 2: Bilateral symmetrical
mesial temporal hyperintensities. (C) Grade 3: Left basal ganglia (caudate) hyperintensity. (D) Grade 4: Both gray and white-matter involvement in the right frontal and
parietal lobes. (E) Grade 5: Diffuse periventricular white matter involvement of both the hemispheres.
Table 5
Predictors of seizure outcome at last follow-up in patients with ePLEDs (N = 52).
Characteristics Persistent seizures (n = 34) Seizure-free (n = 18) Total (n = 52) p* value
Median age (years) 19 26 32 NS
Sex (male:female) 20:14 8:10 28:24 NS
ePLEDs 27 (79.4%) 17 (94.4%) 44 (84.61%) NS
eBiPLEDs 7 (20.5%) 1 (6.5%) 8 (15.38%)
Median Glasgow Coma Scale 11 11 10 NS
Seizures at onset of illness 28 (82.35%) 8 (44.44%) 36 (69.92%) 0.005
Status epilepticus 15 (44.1%) 6 (33.33%) 21 (40.38%) NS
Impaired consciousness at presentation 24 (70.6%) 7 (38.9%) 31 (59.1%) 0.03
Etiology: stroke 7 (20.5%) 8 (44.4%) 15 (28.8%) NS
CNS infection/inﬂammation 17 (50%) 4 (22.2%) 21 (40.38%) 0.05
Metabolic 2 (5.8%) 3 (16.6%) 5 (9.61%) NS
Others 8 (23.5%) 3 (16.6%) 11 (21.15%) NS
Neuroimaginga: Grade 1 7 4 11 NS
Grade 2 7 6 13 NS
Grade 3 2 2 4 NS
Grade 4 7 4 11 NS
Grade 5 11 2 13 NS
a See text for deﬁnition.
* p by Chi-square test/Fisher exact test/t test, NS – not signiﬁcant, ePLEDs – emergent periodic lateralized epileptiform discharges, eBiPLEDs – emergent bilateral
independent periodic lateralized epileptiform discharges, N – number.
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in more than two-third of patients.16,17,19 PLEDs in many studies
have been considered as a surrogate marker of early and high
morbidity and mortality which ranges from 25 to 50%. In our study,
34% of our patients died either during follow-up or while in
hospital.6 Impaired consciousness (p = 0.03) and seizures at
presentation (p = 0.005) predicted a poor long-term seizure
outcome. Patients with CNS infection and/or inﬂammation had
persistent seizures (p = 0.05) during follow-up. The mortality was
higher in eBiPLEDs group as compared to ePLEDs group, although it
did not reach statistical signiﬁcance.
The long-term functional disability was grater in patients with
eBiPLEDs than ePLEDs. The mean MRS was 3 in patients with
eBiPLEDs, whereas it was two in patients with ePLEDs at last
follow-up. This signiﬁes that more number of patients with
eBiPLEDs needed assistance for all activities of daily living and had
a poor quality of life as compared to those with ePLEDs. To our
knowledge, this is the ﬁrst study to look into the risk of long-term
persistent seizures and predictors in patients presenting with
ePLEDs. Our study demonstrated that impaired consciousness and
seizures at presentation are adverse prognostic markers of long-
term seizure outcome in patients with ePLEDs.
5. Conclusion
ePLEDs are a marker of clinical scenarios associated with major
morbidity and signiﬁcant mortality. They are associated with poor
long term seizure outcome. Patients with ePLEDs often develop
serious epileptic seizures during their subsequent hospital stay.This calls for close monitoring of such patients and rigorous seizure
management. Knowledge of the various predictors in a patient
with ePLEDs in their EEG helps the treating neurologist in
prognostication of individual cases.
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